Dendreon Corporation is a leading company in Bridgewater, NJ, revolutionizing medicine through their expertise in cellular technology. With a focus on improving the lives of patients, they develop and deliver innovative science and cellular therapies, including their flagship product PROVENGE sipuleucel-T, the first FDA-approved cellular immunotherapy.
With their extensive experience, knowledge, and logistics, Dendreon also assists other companies in bringing life-saving innovations to market, from clinical research to manufacturing. Joining their team means being part of the future of medicine and making a difference in patients' lives through cellular therapies.
Generated from the website